BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) shares hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $1.70 and last traded at $1.69, with a volume of 41219 shares changing hands. The stock had previously closed at $1.59.
BioRestorative Therapies Price Performance
The firm has a 50 day moving average price of $1.70 and a 200-day moving average price of $1.50. The firm has a market cap of $2.76 billion, a price-to-earnings ratio of -1.49 and a beta of 102.36.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Read More
- Five stocks we like better than BioRestorative Therapies
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
- How to Use the MarketBeat Dividend Calculator
- 2 Option Strategies to Maximize Profits in a Bear Market
- Stock Dividend Cuts Happen Are You Ready?
- Lululemon Stock Gears Up for a Massive Comeback Rally
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.